IMC Chicago
RYTM icon

IMC Chicago’s Rhythm Pharmaceuticals RYTM Stock Holding History

IMC Chicago’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
+13,700
New +$1.33M ﹤0.01% 3093

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

IMC Chicago's RYTM Position: Q1 2026 in Review

IMC Chicago opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 6,697 shares worth $582K. The stake represents ﹤0.01% of the portfolio and ranks #3872 among its holdings.

285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • IMC Chicago held 6,697 shares of Rhythm Pharmaceuticals worth $582K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new IMC Chicago position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3872 holding.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.